LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis

Hepatocellular carcinoma (HCC) is one of the most aggressive human malignancies worldwide. However, the molecular mechanism of HCC metastasis is largely unknown. Long non-coding RNA (lncRNA) plays a key role in gene regulation, and dysregulation of lncRNA is critical to cancer metastasis. LINC01980 has been reported in ESCC recently, but the mechanism underlying its function in HCC is still unknown. In this study, we found that LINC01980 was upregulated and associated with notably poor overall survival in HCC patients. Functionally, LINC01980 played a carcinogenic role and promoted HCC metastasis. Mechanically, LINC01980 enhanced the E2F5 expression via competitively binding miR-376b-5p, thereby inducing epithelial-mesenchymal transition and promoting HCC cells migration and invasion. In addition, LINC01980-mediated HCC cells metastasis was dependent on E2F5. What's more, TGF-beta activated LINC01980 transcription through the canonical TGF-beta/SMAD signaling pathway in HCC. In conclusion, LINC01980, activated by the canonical TGF-beta/SMAD pathway, promoted HCC metastasis via miR-376b-5p/E2F5 axis. Therefore, LINC01980 might be a potential prognostic biomarker and therapeutic target of HCC.

Automated summary

This study found that LINC01980 was upregulated and associated with poor overall survival in HCC patients. It plays a role in promoting HCC metastasis by competitively binding miR-376b-5p, enhancing E2F5 expression, inducing epithelial-mesenchymal transition, and promoting HCC cell migration and invasion. Additionally, TGF-beta activates LINC01980 transcription through the canonical TGF-beta/SMAD signaling pathway in HCC.